½Ã°£ |
¹øÈ£ |
¼º¸í |
¼Ò¼Ó |
Á¦¸ñ |
ÁÂÀå : ¹ÚÀ±±â(¿µ³²ÀÇ´ë) |
13:00~13:40 |
OB1 |
±è½Âö |
ºÎ»êÀÇ´ë |
Placenta bed¿¡¼ÀÇ SDF¿Í visfatinÀÇ ¹ßÇöÀÌ ÀüÀÚ°£Áõ¿¡ ¹ÌÄ¡´Â È¿°ú |
OB2 |
¹èÁöÇý |
°æºÏÀÇ´ë |
Serum NT-proBNP level as a marker for cardiopulmonary function in preeclampsia |
OB3 |
ÇãÇý¿ø |
¿¬¼¼ÀÇ´ë |
C-reactive protein concentrations and differential distributions of leukocytes in Preeclampsia |
OB4 |
¹é¼öÁø |
¿ï»êÀÇ´ë |
Factors predicting failure following selective pelvic arterial embolization for severe postpartum hemorrhage |
ÁÂÀå : ÃÖ¿íȯ(ºÎ»êÀÇ´ë) |
13:40~14:20 |
OB5 |
±èº´Àç |
¼¿ïÀÇ´ë |
ÇÁ·ÎÅ׿À¹Í½º¸¦ ÀÌ¿ëÇÑ »êÀü ½ºÅ×·ÎÀ̵å Åõ¿© ÀüÈÄÀÇ ¾ç¼ö³» ´Ü¹é º¯È ºÐ¼® |
OB6 |
°Á¤¹è |
ÇѸ²ÀÇ´ë |
Self-Reported Exposure to Second-Hand Smoke and Positive Urinary Cotinine in Pregnant Nonsmokers |
OB7 |
õ»óÈÆ |
ÇѾçÀÇ´ë |
Regression toward the mean in the fetal heart rate |
OB8 |
¿À°æÁØ |
¼¿ïÀÇ´ë |
Á¶±â¾ç¸·Æļö »ê¸ð¿¡¼ ¾ç¼ö³» °¨¿°ÀÇ ¿øÀαտ¡ µû¸¥ ¾ç¼ö ¹× ¸ðü ¿°Áõ¹ÝÀÀÀÇ Â÷ÀÌ |
ÁÂÀå : ÀüÁ¾°ü(¼¿ïÀÇ´ë) |
14:20~15:00 |
OB9 |
¼Û½ÂÀº |
¼º±Õ°üÀÇ´ë |
½ÖÅÂÀӽſ¡¼ À¶¸ð¸·¼º¿¡ µû¸¥ ÁÖ»ê±â ÀÌȯ·ü°ú »ç¸Á·ü |
OB10 |
±èÁ¤¸í |
ÀÌÈÀÇ´ë |
ÀÚ°£ÀüÁõ°ú Àڱó» ¼ºÀåÁö¿¬À» º¸ÀÌ´Â ÀÓ»êºÎÀÇ Å¹ݿ¡¼ÀÇ Endothelial nitric oxide synthase, Vascular endothelial growth factor, EndoglinÀÇ ¹ßÇö ºñ±³ |
OB11 |
À̹̹ü |
°üµ¿ÀÇ´ë |
Altered expression of anti-angiogenic factors (sFlt-1, sEng, and VEGF165b) in women who subsequently develop preeclampsia |
OB12 |
¼³ÇöÁÖ |
°æÈñÀÇ´ë |
Placental Catechol-O-methyltransferase expression in the patients with preeclampsia |
ÁÂÀå : È«±â¿¬(¿ø±¤ÀÇ´ë) |
15:00~15:40 |
OB13 |
À̼ø¾Ö |
°æ»óÀÇ´ë |
Antimicrobial Susceptibilities of Ureaplasma urealyticum and Mycoplasma hominis in Pregnant Women of Jinju, Korea |
OB14 |
±è¿¬Èñ |
°¡Å縯ÀÇ´ë |
Temporal gene expression during adipogenic differentiation of human chorion derived stem cells |
OB15 |
Á¶±ÝÁØ |
°í·ÁÀÇ´ë |
D6 decoy receptor in missed abortion |
OB16 |
ÀÌ°æÁø |
Â÷ÀÇ´ë |
ÁøÅë Áß Àΰ£Å¹ݿ¡¼ À¯¹ßµÇ´Â À¯ÀüÀÚ ¹ßÇö º¯ÈÀÇ È®ÀÎÀ» À§ÇÑ mRNA oligonucleotide ¹Ì¼¼¹è¿¹ýÀÇ ÀÌ¿ë |
ÁÂÀå : ±è»çÁø(°¡Å縯ÀÇ´ë) |
15:40~16:20 |
OB17 |
ÃÖ¼¼°æ |
°¡Å縯ÀÇ´ë |
Á¦´ëÇ÷ Base excess¿Í ÅÂ¾Æ »êÇ÷Áõ ¹× ½Å»ý¾Æ ¿¹ÈÄÀÇ »ó°ü°ü°è |
OB18 |
¼Àº¼º |
¼º±Õ°üÀÇ´ë |
ÀӽŠÀü ÀڱðæºÎ ¿øÃßÀýÁ¦¼úÀ» ½ÃÇà ¹ÞÀº ÀÓ»êºÎ¿¡¼ Á¶»êÀ² ¹× ¿¹¹æÀû ÀڱðæºÎ ¿øÇü°áÂûÀÇ È¿°ú |
OB19 |
±èÇý¹Î |
À»ÁöÀÇ´ë |
ÀڱðæºÎ ¿ø»ÔÀýÁ¦¼úÀÌ Àӽſ¡ ¹ÌÄ¡´Â ¿µÇâ |
OB20 |
Á¤È¿¿µ |
Á¶¼±ÀÇ´ë |
ÅÂ¾Æ ½ÉÃÊÀ½Æĸ¦ À§ÇØ »ïÂ÷ÀÇ·á±â°üÀ¸·Î Àü¿øµÇ´Â ȯÀÚµéÀÇ ÀûÀÀÁõ¿¡ ´ëÇÑ ºÐ¼® |
ÁÂÀå : ¼ÕÀμ÷(°Ç±¹ÀÇ´ë) |
16:20~17:00 |
OB21 |
±è¼®¿µ |
°¡ÃµÀÇ´ë |
Assessment of a single value of hyperglycemia to predict the macrosomia in gestational diabetes mellitus(GDM) |
OB22 |
±èÁ¾¿î |
Àü³²ÀÇ´ë |
Àӽżº ´ç´¢¿Í Ä¡·á ÁßÀÎ Çö¼º´ç´¢ ÀӺο¡¼ Ç×»ýÁ¦ ºÎÄ¡ ÈÄ Á¤¸ÆÇ÷Àå³» ÁöÁú°ú»êȵµ¿Í ´Ü¹é»êȵµÀÇ º¯È |
OB23 |
¼Õ°¡Çö |
¿¬¼¼ÀÇ´ë |
Effect of maternal insulin resistance on fetal growth in women with gestational diabetes mellitus (GDM) |
OB24 |
±è½ÅÇý |
°üµ¿ÀÇ´ë |
Association between First-and Second-Trimester Serum Screening Markers and Pregnancy Outcomes |